EMA safe­ty com­mit­tee seeks more in­fo on heart in­flam­ma­tion fol­low­ing Pfiz­er Covid-19 vac­cine

The Eu­ro­pean Med­i­cines Agency’s safe­ty com­mit­tee said Fri­day that it’s aware of cas­es of in­flam­ma­tion of the heart mus­cle and in­flam­ma­tion of the mem­brane around the heart, main­ly re­port­ed fol­low­ing vac­ci­na­tion with Pfiz­er’s Covid-19 vac­cine, known in Eu­rope as Comir­naty.

“There is no in­di­ca­tion that these cas­es are due to the vac­cine,” the EMA’s Phar­ma­covig­i­lance Risk As­sess­ment Com­mit­tee said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER